Scientists at The University of Texas at El Paso have found a promising new target in the fight against high-grade serous ...

A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Keytruda plus platinum-based chemotherapy was found to be both safe and efficacious in treating penile squamous cell carcinoma (PSCC), according to findings from the phase 2 HERCULES trial presented ...

A new study published in the Journal of Clinical Investigation has identified biomarkers that predict the likelihood of a patient developing checkpoint inhibitor-associated autoimmune diabetes before ...

We read with interest the Article by Daniel Ma and colleagues in The Lancet Oncology.1 Ma and colleagues should be ...

Primary pulmonary nuclear protein of the testis (NUT) midline carcinoma (NMC) is an extremely rare, highly aggressive thoracic malignancy that ...

The Anal Cancer Market is led by North America; the market is shaped by increasing R&D funding for HPV-Positive tumor immunotherapy and growing acceptance of chemoradiation organ-preservation ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...

TuHURA Biosciences faces high investment risk amid cash shortages, dilution threats, and distant trial results. Click to read my latest analysis of HURA stock.

Dear Dr. Roach: I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a week. I'm writing because during a routine dental cleaning, my dentist noticed ...

A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated ...

Please provide your email address to receive an email when new articles are posted on . A genomic test predicts individual risk for metastasis after a cutaneous squamous cell carcinoma diagnosis. Two ...